SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-19-004818
Filing Date
2019-04-26
Accepted
2019-04-25 18:40:49
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-3 azrx_s3.htm S-3 323333
2 CONSENTS OF EXPERTS AND COUNSEL ex23-1.htm EX-23.1 4299
3 IMAGE azurrx_logo000.jpg GRAPHIC 6140
  Complete submission text file 0001654954-19-004818.txt   337290
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: S-3 | Act: 33 | File No.: 333-231035 | Film No.: 19768774
SIC: 2834 Pharmaceutical Preparations